InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain
InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
LRG | Ann: Results of Meeting | 13/01/14 | 0 | 353 | |||
|
|||||||
LRG | Ann: Suspension from Official Quotation | 13/01/14 | 0 | 317 | |||
|
|||||||
LRG | Ann: Final Director's Interest Notice | 13/01/14 | 0 | 326 | |||
|
|||||||
LRG | Ann: Trading Halt | 13/01/14 | 0 | 238 | |||
|
|||||||
LRG | Ann: Chairman's Address to Shareholders | 13/01/14 | 0 | 322 | |||
|
|||||||
LRG | Ann: Notice of Annual General Meeting/Proxy Form | 11/12/13 | 0 | 173 | |||
|
|||||||
LRG | Ann: Date of Annual General Meeting | 20/11/13 | 0 | 203 | |||
|
|||||||
LRG | Ann: Extension of time to hold AGM | 17/10/13 | 0 | 217 | |||
|
See All Discussions